Compare · OMCL vs ZEPP
OMCL vs ZEPP
Side-by-side comparison of Omnicell Inc. (OMCL) and Zepp Health Corporation (ZEPP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OMCL and ZEPP operate in Computer Manufacturing (Technology), so they compete in similar markets.
- OMCL is the larger of the two at $1.96B, about 21.5x ZEPP ($90.8M).
- OMCL has been more active in the news (15 items in the past 4 weeks vs 2 for ZEPP).
- OMCL has more recent analyst coverage (24 ratings vs 0 for ZEPP).
- Company
- Omnicell Inc.
- Zepp Health Corporation
- Price
- -
- -
- Market cap
- $1.96B
- $90.8M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Computer Manufacturing
- Computer Manufacturing
- Exchange
- NASDAQ
- NYSE
- IPO
- 2001
- News (4w)
- 15
- 2
- Recent ratings
- 24
- 0
Omnicell Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. In addition, the company provides automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; single dose automation solutions to fill and label for incoming prescriptions; semi-automated filling equipment for the long-term care institutional pharmacy; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Zepp Health Corporation
Zepp Health Corporation, a biometric and activity data-driven company, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and a range of accessories, including bands, watch straps, earphones, sportswear, home gym, treadmill, etc. under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Mi Fit and Amazfit mobile apps. Zepp Health Corporation has strategic collaborations with Timex Group to develop smart watches; and AliveCor, Inc. to deliver a medical functionality to wearable devices. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
Latest OMCL
- Director Bousa Edward Peter was granted 4,603 shares, increasing direct ownership by 26% to 22,589 units (SEC Form 4)
- Director Scott Bruce E was granted 4,627 shares, increasing direct ownership by 20% to 27,600 units (SEC Form 4)
- Director Seim Robin Gene was granted 4,845 shares, increasing direct ownership by 10% to 52,198 units (SEC Form 4)
- Director Voynick Eileen J. was granted 4,785 shares, increasing direct ownership by 31% to 20,011 units (SEC Form 4)
- Director Parrish Mark W was granted 4,845 shares, increasing direct ownership by 7% to 70,100 units (SEC Form 4)
- Director Bauer Joanne B was granted 5,027 shares, increasing direct ownership by 11% to 49,922 units (SEC Form 4)
- Director Garrett Mary was granted 5,027 shares, increasing direct ownership by 29% to 22,202 units (SEC Form 4)
- Director Ghoshal Kaushik was granted 4,603 shares, increasing direct ownership by 32% to 19,123 units (SEC Form 4)
- Omnicell to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
- SEC Form SD filed by Omnicell Inc.
Latest ZEPP
- Amazfit Introduces a New Era of Hybrid Training with Balance 3 and Balance Ultra
- Zepp Health Corporation to Report First Quarter 2026 Financial Results on June 8, 2026
- Amazfit Unveils the Cheetah 2 Ultra: The Performance Trail Running Watch Built to Master the Toughest Mountain Trails
- Amazfit Unveils the Cheetah 2 Pro, a Performance Running Watch Built for Marathon Preparation
- Amendment: SEC Form SCHEDULE 13G/A filed by Zepp Health Corporation
- Zepp Health Corporation Files 2025 Annual Report on Form 20-F
- SEC Form 20-F filed by Zepp Health Corporation
- Amazfit Unveils the Cheetah 2 Pro, a Performance Running Watch Built for Marathon Preparation
- HYROX and Amazfit Strengthen Alliance With Global Three-Year Partnership
- SEC Form 3 filed by new insider Xie Bing (Brian)